LOGIN
AAOS2017: Liposomal bupivacaine not advantageous for intraarticular analgesia in TKA
March 2017
AAOS2017: Liposomal bupivacaine not advantageous for intraarticular analgesia in TKA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Effectiveness of Intraoperative Bupivacaine Liposome Injectable Suspension for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double-blind, Controlled Study
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
96 patients scheduled for unilateral total knee arthroplasty and managed with intraoperative, intraarticular infiltration analgesia as part of a multimodal analgesia regimen were randomized to injection of a drug mixture with or without liposomal bupivacaine. Patients were assessed postoperatively for narcotic consumption, pain scores, time to the ability to walk 100 feet, and the length of hospit...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.